1.Hot issues of immunology in viral hepatitis C.
Chinese Journal of Hepatology 2009;17(7):490-493
Animals
;
Antigens, CD
;
immunology
;
Cytokines
;
metabolism
;
Hepacivirus
;
immunology
;
Hepatitis C
;
immunology
;
prevention & control
;
virology
;
Hepatitis C Antibodies
;
biosynthesis
;
immunology
;
Hepatitis C Antigens
;
immunology
;
Humans
;
Killer Cells, Natural
;
immunology
;
T-Lymphocytes
;
immunology
;
metabolism
;
T-Lymphocytes, Regulatory
;
immunology
;
metabolism
;
Viral Proteins
;
immunology
2.Antigencity identification of recombinant hepatitis E virus ORF2 protein expressed in Pichia pastoris.
Yu-pin TONG ; Sheng-li BI ; Jian LU ; Yong-zhen JIANG ; Mei-yun ZHAN
Chinese Journal of Experimental and Clinical Virology 2003;17(3):258-261
BACKGROUNDTo determine the antigenicity of recombinant hepatitis E virus ORF2 (rHEV ORF2) protein expressed in Pichia pastoris (P. pastoris).
METHODSBy using the rHEV ORF2 protein from E.coli as control, an indirect ELISA was adopted to identify the sensitivity, specificity and stability of rHEV ORF2 protein from P. pastoris in detection of HEV IgM and IgG antibody in sera from patients with hepatitis E. The reactivity of the rHEV ORF2 against 5 HEV ORF2 monoclonal antibodies (McAbs) was also tested.
RESULTSThe minimum concentration of coated antigen with which HEV IgG could be detected was 12.5 ng/ml, while the highest serum dilution to detect both IgM and IgG antibodies against HEV was 1:5 120. No cross-reaction was found with sera from patients with any other types of hepatitis. The 37 degree C acceleration test showed that the rORF2 was highly stable within 12 months at 4 degrees C. The 5 HEV ORF2 McAbs showed better reaction with the rORF2 from P. pastoris, especially that 4B2, 2E2, whose reaction against the rORF2 were 125 and 25 times respectively higher than that of rORF2 from E.Coli.
CONCLUSIONThere may be more extensive conformational epitopes in the rHEV ORF2 from P. pastoris. The excellent antigenicity, sensitivity and stability suggest that it can be served as a new candidate antigen for the development of diagnostic reagents of hepatitis E.
Gene Expression ; Hepatitis Antibodies ; blood ; Hepatitis Antigens ; genetics ; immunology ; Hepatitis E ; immunology ; Hepatitis E virus ; genetics ; immunology ; Humans ; Pichia ; genetics ; metabolism ; Recombinant Proteins ; genetics ; immunology ; Viral Proteins ; genetics ; immunology
3.Incidence and Seroprevalence of Hepatitis A Virus Infections among Young Korean Soldiers.
Cheol In KANG ; Chang Min CHOI ; Tae Sung PARK ; Dong Jun LEE ; Myoung Don OH ; Kang Won CHOE
Journal of Korean Medical Science 2007;22(3):546-548
This study was performed to determine the incidence and seroprevalence of hepatitis A virus (HAV) infections in young soldiers in the Republic of Korea Army. From January 2000 through December 2004, a total of 147 hepatitis A cases were reported to the Armed Forces Medical Command. The annual incidence rates were 7.4 per 100,000 persons in 2000, 1.6 in 2001, 4.4 in 2002, 9.8 in 2003, and 6.2 in 2004, based on the reported cases among approximately 500,000 soldiers. All patients were males with a median age of 21 yr (range, 19-27). The most common symptom was nausea (86.5%), and all patients had recovered without complications. In addition, in order to evaluate the seroprevalence of HAV infection in young adults, serum samples were obtained from randomly selected young subjects among those who had been admitted to the Armed Forces Capital Hospital from September 2005 to February 2006. A total of 200 subjects were enrolled in the study to analyze the anti-HAV immune status. The overall anti-HAV IgG seropositive rate was 2% (4/200, 95% CI, 0.60-5.21%). Given the changing epidemiology of the disease and the associated increase in morbidity, it was suggested that the routine HAV vaccination for Korean military personnel might be necessary.
Adult
;
Hepatitis A/*blood/*epidemiology/immunology
;
Hepatitis A Antibodies/immunology
;
Hepatitis A virus/*metabolism
;
Humans
;
Immunoglobulin G/blood
;
Incidence
;
Korea
;
Male
;
Military Personnel
;
Seroepidemiologic Studies
4.Definition, Diagnosis, and Prevalence of Occult Hepatitis B Virus Infection.
The Korean Journal of Gastroenterology 2013;62(3):143-147
Occult HBV infection is characterized by the absence of serum HBsAg with persistence of low level of intrahepatic HBV DNA. Several suggested mechanisms for the origin of occult HBV infection include strong suppression of viral replication and gene expression, mutation in the regulatory regions of HBV genome, formation of immunoglobulin-bound HBsAg, viral interference, and blockage of HBsAg secretion from infected hepatocytes. Standardized assays are not yet available, and sensitive HBV DNA amplification assay is necessary for the diagnosis of cryptic infection. Detection rate of HBV DNA is highest in IgG anti-HBc positive population. However, neither anti-HBc nor anti-HBs can be detected in a significant proportion of infected persons. Occult HBV infection occurs in a number of clinical settings and is highly prevalent in HCV-infected patients as well as in patients with cryptogenic chronic liver disease including hepatocellular carcinoma.
DNA, Viral/analysis
;
Hepatitis B/*diagnosis/*epidemiology/metabolism
;
Hepatitis B Antibodies/blood
;
Hepatitis B Core Antigens/immunology
;
Hepatitis B Surface Antigens/blood
;
Humans
5.Screening and application of human-derived HBsAg bacteriophage single chain antibody in clinical diagnosis.
Yanwei ZHONG ; Jun CHENG ; Shuangshuang SHI ; Jingmin ZHAO ; Gang WANG ; Xiaobing XIA ; Xiaojun TIAN ; Li LI ; Lingxia ZHANG
Chinese Journal of Experimental and Clinical Virology 2002;16(3):223-225
OBJECTIVETo identify human single chain Fv antibody (ScFv) against hepatitis B viral surface antigen.
METHODSThe recombinant phages were panned by HBsAg which was coated in a microtiter plate, after five rounds of biopanning, 56 phage clones were identified specific to HBsAg. The specificity of ScFv was evaluated by ELISA and immunohistochemistry, respectively.
RESULTSThe data of HB sAg-ScFv DNA digestion and DNA sequencing showed that the ScFv gene is composed of 750 bp. ELISA and immunohistochemistry demonstrated that the human single chain Fv antibody against hepatitis B surface antigen has a specific combination character with hepatitis B surface antigen of different sources and paraffin-embedded patients tissue specimens, it did not react with normal liver tissue and HCV.
CONCLUSIONSThe application of HBsAg specific ScFv in immunohistochemistry was successfully achieved.
Bacteriophages ; metabolism ; Enzyme-Linked Immunosorbent Assay ; Hepatitis B Antibodies ; Hepatitis B Surface Antigens ; immunology ; Hepatitis B, Chronic ; diagnosis ; Humans ; Peptide Library
6.Study on the differences of two mouse models of hepatitis B virus infection by transduction with rAAV8-1. 3HBV.
Gang WANG ; Xiao-Yan DONG ; Wen-Hong TIAN ; Chi-Jie YU ; Gang ZHENG ; Jie GAO ; Guo-Jing WANG ; Guo-Chao WEI ; Yu-Sen ZHOU ; Xiao-Bing WU
Chinese Journal of Virology 2012;28(5):541-547
We recently developed a mouse model of hepatitis B virus (HBV) chronic infection by intravenous (i.v.) injection with rAAV8-1. 3HBV to C57BL/6 mice. To define the responses of different mouse strains after injection with rAAV8-1. 3HBV, we intravenously injected rAAV8-1. 3HBV at doses of 4 x10(9) (Viral genome,vg), 4 x 10(10) vg and 4 x 10(11) vg to C57BL/6 and BALB/c mice,respectively, and determined the levels of serum HBV antigen and antibody by ELISA,serum viral DNA by real-time PCR,and HBcAg expression in liver by immunohistochemical staining. For C57BL/6 mouse strain with injection of rAAV8-1. 3HBV at three doses, 100% of the mice carried HBV for more than 8 months. The levels of serum HBsAg and HBeAg, serum viral DNA and HBcAg-positive hepatocytes increased in a rAAV8-1. 3HBV dose-dependent manner. For C57BL/6 mice injected with rAAV8-1. 3HBV at the dose of 4 x 10(11) vg,over 40% of hepatocytes expressed HBcAg and serum viral DNA reached over 10(5) IU/mL. No HBV antibody was detected in sera of C57BL/6 mice. For BALB/c mice with injection of rAAV8-1. 3HBV at three doses, serum HBeAg, serum viral DNA and HBcAg-positive hepatocytes persisted for more than 8 months, but serum HBsAg declined remarkably at 2 weeks after injection. The levels of serum HBeAg and HBcAg-positive hepatocytes in BALB/c mice increased in a rAAV8-1. 3HBV dose-dependent manner. Injection with rAAV8-1. 3HBV at the dose of 4 x 10(11) vg resulted in over 50% of BALB/c mice hepatocytes expressing HBcAg. Serum anti-HBsAg were detected in BALB/c mice with rAAV8-1. 3HBV injection at the dose of 4 x10 (10) vg. In conclusion, both C57BL/6 and BALB/c strains can be developed to chronic HBV infection mouse models by i. v. injection with rAAV8-1. 3HBV at doses of 4 x10(9) - 4 x 10(11) vg and the levels of HBV replication increase in a rAAV8-1. 3HBV dose-dependent manner. In contrast to C57BL/6 strain, the BALB/c mice carry out humoral immunity to HBsAg, but fail to mediate HBV clearance.
Animals
;
Dependovirus
;
genetics
;
metabolism
;
Disease Models, Animal
;
Genetic Vectors
;
genetics
;
metabolism
;
Hepatitis B
;
immunology
;
virology
;
Hepatitis B Antibodies
;
immunology
;
Hepatitis B Surface Antigens
;
immunology
;
Hepatitis B e Antigens
;
immunology
;
Hepatitis B virus
;
genetics
;
immunology
;
physiology
;
Hepatocytes
;
immunology
;
virology
;
Humans
;
Male
;
Mice
;
Mice, Inbred BALB C
;
Mice, Inbred C57BL
;
Transduction, Genetic
;
Virus Replication
7.Effects of HBsAg pulsed dendritic vaccination on anti-HBs production in immunosuppressed rats after liver transplantation.
Yue LI ; Xian-Feng CHEN ; Zuo-Jin LIU ; Jian-Ping GONG ; Sheng-Wei LI
Chinese Journal of Hepatology 2010;18(1):32-36
OBJECTIVETo explore the effects of HBsAg pulsed dendritic vaccination on anti-HBs production in immunosuppressed rats after liver transplantation (LT).
METHODSBrown-Norway liver allografts were transplanted into Lewis recipients. The transplanted Lewis rats were injected with EK506 (2 mg/kg) and randomly divided into two groups: rats in HBsAg-DCs group (n = 15) were intraperitoneally injected with HBsAg pulsed DCs at 14 d and 28 d after LT, and rats in the HBsAg group (n = 15) were injected with HBsAg (200 mul) once a week for 12 weeks. Rats without any immunosuppressive treatment after LT served as controls (n = 5). IL-2 and IFN-gamma mRNA expression in spleen were analyzed by RT-PCR, serum IL-2, IFN-gamma and anti-HBs were detected by ELISA.
RESULTSHigh dose of FK506 resulted in the immunosuppressed in LT rats, as evident by low production of IL-2 and IFN-gamma, and without liver rejection compared to rats in the control group. HBsAg-DCs induced high titer of anti-HBs antibody, however, titer of anti-HBs were seldom detectable in the HBsAg group at 1, 2 and 3 mouth after vaccination.
CONCLUSIONThe capacity of HBsAg-DCs to induce anti-HBs in immunosuppressed rats suggested that DC vaccine may prevent HBV recurrence in liver transplanted patients.
Adjuvants, Immunologic ; pharmacology ; Animals ; Cytokines ; blood ; genetics ; metabolism ; Dendritic Cells ; immunology ; Disease Models, Animal ; Hepatitis B ; immunology ; prevention & control ; Hepatitis B Antibodies ; blood ; immunology ; Hepatitis B Surface Antigens ; immunology ; Hepatitis B Vaccines ; Immunosuppression ; Immunosuppressive Agents ; administration & dosage ; Liver Transplantation ; immunology ; Male ; RNA, Messenger ; genetics ; metabolism ; Random Allocation ; Rats ; Rats, Inbred BN ; Rats, Inbred Lew ; Secondary Prevention ; Spleen ; immunology ; metabolism
8.Expression of a human single-chain Fv antibody against HBsAg in Pichia pastoris.
Sheng XIONG ; Xiang-Rong REN ; Yong-Hong TANG ; Kuan-Yuan SU ; Zhou-Yao YU ; Yong LUO ; Yi-Fei WANG ; Jiu-Xiang LI
Chinese Journal of Biotechnology 2003;19(1):19-23
To express and secrete native HBscFv (anti-HBsAg single-chain Fv) in P. pastoris, HBscFv was amplified from plasmid pGEM-HBscFv, and then sub-cloned into expression vector pPICZalphaA. The resulting plasmid pPIC-HBscFv was linearized and transformed into P. pastoris GS115. The recombinant Pichia strains, identified by direct PCR and Zeocin-resistant screening of Pichia transformants, were cultured and induced with methanol. It was found that recombinant HBscFv, lead by alpha-factor, could be secreted into the culture supernatant to a level of 80mg/L. The bioactivity of Pichia produced HBscFv was confirmed by indirect ELISA, which also suggested that the bioactivity of HBscFv in the culture supernatant reached its peak in 72h and decreased in the late-stage of the induction. PAS staining suggests that HBscFv produced by yeast is poorly glycosylated or none-glycosylated protein.
Blotting, Western
;
Electrophoresis, Polyacrylamide Gel
;
Hepatitis B Surface Antigens
;
immunology
;
Humans
;
Pichia
;
genetics
;
metabolism
;
Polymerase Chain Reaction
;
Single-Chain Antibodies
;
genetics
;
immunology
;
metabolism
9.Selection of a peptide mimic the neutralization epitope of hepatitis E virus with phage peptide display technology.
Ying GU ; Jun ZHANG ; Ying-Bin WANG ; Shao-Wei LI ; Hai-Jie YANG ; Wen-Xin LUO ; Ning-Shao XIA
Chinese Journal of Biotechnology 2003;19(6):680-685
Hepatitis E is an acute hepatitis casused by hepatitis E virus (HEV) in developing countries, where it occurs as cases sporadic and in epidemics form. The causative agent, hepatitis E virus, is transmitted primarily by the fecal-oral route. HEV is icosahedron non-enveloped virus, and its genome is a single-stranded, positive-sense, 3'-polyadenylated RNA about 7.5 kb in length. It contains three open reading frames (ORFs). Of which ORF1 codes for a polyprotein of 1693 amino acids and contain domains homologous to a viral methyltransferase, a papainlike cysteine protease, an RNA helicasre, and an RNA-dependent RNA polymerase, besides the most hypervariable region of the HEV genome. And ORF3 codes for a 123-amino-acide-long polypeptide with unknown function. While the major viral capsid protein (pORF2, ORF2 codes) of 660 amino acid was showed to contain the protective epitope. The bacterially expressed polypeptide disignated as NE2 has been proved to be a protective antige. And the anti-NE2 monoclonal antibodies (mAb) was screend, two of these mAbs 8C11 and 8H3 were showed to be against separate conformational neutralization epitope of hepatitis E virus (HEV). And these two mAb were used to screen for binding peptides from a 7-peptides phage display library. After four rounds of panning, tweenty-one positive monoclonal phages (11 for 8C11, and 10 for 8H3) were selected and the inserted fragments were sequenced. The DNA sequence coding for the obtained dominant peptide 8C11 (N'-His-Pro-Thr-Leu-Leu-Arg-Ile-C', named 8C11A) and 8H3 (N'-Ser-Ile-Leu-Pro-Tyr-Pro-Tyr-C', named 8H3A) were then synthesized and cloned to insert between amino acid 78 to 83 of hepatitis B core antigen (HBcAg), then expressed in E. coli. The recombinant proteins aggregate into homodimer or polymer on SDS-PAGE, and could bind with mAb 8C11 and 8H3 in Western blotting. Respectively, the recombinant protein C8C11A showed to be dimer mainly, which can bind with mAb 8C11. The monomer and dimer of C8H3A are in the same amount on SDS-PAGE, but only the dimer could bind with mAb 8H3 on Western blotting. The renatured recombinant proteins were all showed to aggregate into virus like particles which were similar as HBcAg on transmission electron micrograph. The dominant peptide 8H3A (N'-Ser-Ile-Leu-Pro-Tyr-ProTyr-C') that selected out by mAb 8H3 was further chemo-synthesized, and its binding activity was confirmed by BIAcore biosensor. The result showed that this 7-peptide can bind with mAb 8H3 in a big Ka and Kd form, which means the binding is not stable. These results implicated that conformational dependent neutralization epitope could be partially modeled by short peptide, which provided a feasible route for subunit vaccine development.
Amino Acid Sequence
;
Animals
;
Antibodies, Monoclonal
;
immunology
;
Blotting, Western
;
Electrophoresis, Polyacrylamide Gel
;
Epitopes
;
chemistry
;
genetics
;
immunology
;
metabolism
;
Hepatitis B Core Antigens
;
genetics
;
metabolism
;
Hepatitis E virus
;
genetics
;
immunology
;
metabolism
;
Mice
;
Microscopy, Electron
;
Molecular Sequence Data
;
Peptide Library
;
Peptides
;
chemistry
;
genetics
;
immunology
;
metabolism
;
Recombinant Proteins
;
genetics
;
immunology
;
metabolism
;
ultrastructure
;
Sequence Homology, Amino Acid
;
Viral Proteins
;
chemistry
;
genetics
;
immunology
;
metabolism
;
ultrastructure
10.Clinical Features of Acute Hepatitis A in Recent Two YearsClinical Features of Acute Hepatitis A in Recent Two Years.
Eung Jun LEE ; So Young KWON ; Tae Ho SEO ; Hyun Sung YUN ; Han Su CHO ; Byung Kook KIM ; Won Hyeok CHOE ; Chang Hong LEE ; Jin Nam KIM ; Hyung Joon YIM
The Korean Journal of Gastroenterology 2008;52(5):298-303
BACKGROUND/AIMS: The purpose of this study was to characterize the clinical features of acute hepatitis A in Seoul and Gyeonggi province during the recent 2 years. METHODS: We reviewed the medical records of 222 patients who were diagnosed as acute hepatitis A between August 2005 and March 2007 at the Konkuk University Hospital and Korea University, Ansan Hospital. The clinical manifestation, serological tests, and image findings were analyzed. RESULTS: Median age of the patients was 28.1 years and the age groups of highest incidence were the second and third decade. The frequent symptoms were anorexia (66.4%), fatigue (49.2%), fever (47.7%), and abdominal discomfort (42.5%). Fourteen cases (6.3%) showed renal insufficiency, and hemodialysis was performed in one. Cholestatic hepatitis in 2 cases, relapsing hepatitis in 4 cases and prolonged hepatitis in 13 cases were observed. However, there was no case of fulminant hepatitis or death. The underlying diseases including chronic hepatitis B, diabetes mellitus and thyroid disorder did not affect the disease severity of hepatitis A. IgM anti-HAV was not detected initially in 6.7% of the patients. Anti-HEV (IgM) was detected simultaneously in 3 of 150 patients. CONCULSIONS: The age of patients with acute hepatitis A has been increased in the recent years. Most patients recovered uneventfully. However, unusual patterns of severe hepatitis and renal insufficiency occurred in considerable number of cases. Follow-up serologic test for IgM anti-HAV is needed in seronegative cases with hepatitis A
Acute Disease
;
Adolescent
;
Adult
;
Age Distribution
;
Child
;
Child, Preschool
;
Female
;
Hepatitis A/*diagnosis/immunology
;
Hepatitis A Antibodies/metabolism
;
Hepatitis A Virus, Human/immunology
;
Humans
;
Immunoglobulin M/blood
;
Male
;
Middle Aged
;
Serologic Tests
;
Suburban Population